{"id":"cpl500036-low-dose","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL2108580","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, there is limited information available about the mechanism of action of CPL500036.","oneSentence":"CPL500036 is a low-dose drug with an unknown existing mechanism.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:29:27.643Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05278156","phase":"PHASE2","title":"Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia","status":"COMPLETED","sponsor":"Celon Pharma SA","startDate":"2021-05-19","conditions":"Schizophrenia","enrollment":189},{"nctId":"NCT05297201","phase":"PHASE2","title":"Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients with Levodopa Induced Dyskinesia","status":"COMPLETED","sponsor":"Celon Pharma SA","startDate":"2021-11-02","conditions":"Parkinson Disease, Dyskinesia, Medication-Induced","enrollment":105}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CPL500036 - low dose","genericName":"CPL500036 - low dose","companyName":"Celon Pharma SA","companyId":"celon-pharma-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}